Arcadia, CA, United States of America

Samantha Chang-Lin

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Academia Sinica, Mello Biotech Taiwan Co., Ltd., Wjwu & Lynn Institute for Stem Cell Research and Mello Biotechnology. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samantha Chang-Lin. Retrieved from https://idiyas.com/inventor/samantha-chang-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 60.0


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Samantha Chang-Lin

Introduction

Samantha Chang-Lin is a prominent inventor based in Arcadia, California. She has made significant contributions to the field of stem cell research and therapeutic innovations. With a total of four patents to her name, her work focuses on advancing medical treatments and understanding cellular mechanisms.

Latest Patents

One of her latest patents is titled "In-vitro induction of adult stem cell expansion and derivation." This invention relates to a composition and its method of use for inducing adult stem cell (ASC) expansion and/or derivation in vitro. It utilizes miR-302-like pre-miRNAs, shRNAs, and/or siRNAs, which contain a shared sequence in the 5'-end. The invention also incorporates wound-healing-related factors, such as basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF). The principle of this invention is based on a novel mechanism of inducible symmetric ASC division found in a skin wound healing model. The amplified ASCs resulting from this process are useful for treating various disorders, including Alzheimer's disease and cancer.

Another significant patent is for "Trimethylglycylglycerin compositions and their use in developing anti-cancer drugs and RNA vaccines." This invention involves novel chemical compositions for formulating RNA- and/or DNA-based medicine drugs and vaccines. It teaches the synthesis of trimethylglycyl chemicals for creating stable compound complexes that can deliver nucleic acid compositions effectively. This innovation has potential applications in both therapeutic and pharmaceutical settings.

Career Highlights

Samantha has worked with several organizations, including the Wjwu & Lynn Institute for Stem Cell Research and Mello Biotechnology. Her work has been instrumental in advancing the understanding of stem cell applications in medicine.

Collaborations

Throughout her career, Samantha has collaborated with notable individuals such as Shi-Lung Lin and Donald C Chang. These collaborations have further enriched her research and contributions to the field.

Conclusion

Samantha Chang-Lin's innovative work in stem cell research and therapeutic development showcases her dedication to advancing medical science. Her patents reflect her commitment to addressing complex health issues through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…